The strong of OTC drugs, Dongwha Pharm, expanded to CNS infections

Published: 2015-03-24 14:53:26

Updated: 2015-03-24 14:53:26

The oldest company, Dongwha Pharm, has domestically acquired an approval for the new quinolones-type antibiotic for the third time after Factive and Q-Roxin.

On the last 20^th, Dongwha has acquired a product approval for the self-developed quinolones-type antibiotic ‘Zabolante’. The indicant of the drug is to treat the chronic obstructive pulmonary disease’s acute bacterial exacerbation.

The c...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.